4.5 Review

Minireview: 3-Iodothyronamine (T(1)AM): A New Player on the Thyroid Endocrine Team?

Journal

ENDOCRINOLOGY
Volume 150, Issue 3, Pages 1108-1111

Publisher

ENDOCRINE SOC
DOI: 10.1210/en.2008-1596

Keywords

-

Funding

  1. National Institutes of Health [DK-52798]
  2. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052798, R01DK052798] Funding Source: NIH RePORTER

Ask authors/readers for more resources

3-Iodothyronamine (T(1)AM) is an endogenous compound with chemical features that are similar to thyroid hormone. T(1)AM has a carbon skeleton identical to that of T-4 and contains a single carbon-iodine bond. Theoretically, T(1)AM could be produced from T-4 by enzymatic decarboxylation and deiodination. Recent studies show that T(1)AM and higher iodinated thyronamines are subject to similar metabolic processing as iodothyronines such as T-4, suggesting a biological linkage between iodothyronines and iodothyronamines. In addition, single doses of T(1)AM administered to rodents induce a hypometabolic state that in certain ways resembles hibernation and is opposite to the effects of excess T-4. This review will discuss the latest developments on this recently discovered thyroid hormone derivative. (Endocrinology 150: 1108-1111, 2009)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available